Walleye Trading’s Adaptive Biotechnologies ADPT Stock Holding History

Walleye Trading’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-72,600	Closed	-$517K	–	4912
2022 Q3	$517K	Sell	72,600 -17,000	-19%	-$160K	﹤0.01%	2876
2022 Q2	$725K	Buy	89,600 +82,900	+1,237%	+$729K	﹤0.01%	2535
2022 Q1	$93K	Buy	6,700 +3,300	+97%	+$51.9K	﹤0.01%	4280
2021 Q4	$95K	Buy	+3,400	New	+$104K	﹤0.01%	4401
2021 Q2	–	Sell	-1,500	Closed	-$60K	–	5086
2021 Q1	$60K	Buy	+1,500	New	+$81.2K	﹤0.01%	4279
2020 Q4	–	Sell	-9,500	Closed	-$462K	–	4536
2020 Q3	$462K	Sell	9,500 -11,400	-55%	-$479K	﹤0.01%	2309
2020 Q2	$1.01M	Buy	+20,900	New	+$762K	0.01%	1658

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Trading's ADPT Position: Q1 2022 in Review

Walleye Trading sold out of Adaptive Biotechnologies (ADPT) in Q1 2022, closing a stake of 4,555 shares — an estimated $71.6K sold.

Walleye Trading first reported a position in ADPT in Q1 2021 and held it in 2 quarters. The position peaked at $130K in Q1 2021. 221 funds tracked by Wall St. Rank hold ADPT as of Q1 2022.

Walleye Trading reported no remaining Adaptive Biotechnologies position as of Q1 2022 after selling out during the quarter.
Walleye Trading sold 4,555 Adaptive Biotechnologies shares in Q1 2022, an estimated $71.6K.
Walleye Trading first reported a position in Adaptive Biotechnologies in Q1 2021 and held it in 2 quarters.
Walleye Trading's Adaptive Biotechnologies position peaked at $130K in Q1 2021.
221 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2022.

Based on Walleye Trading's 13F filing for Q1 2022, filed 16 May 2022.